Steven Mortier joins Oncoteq AG as Global Program Leader

Steven Mortier joins Oncoteq AG as Global Program Leader

We are pleased to inform you that Steven Mortier is joining us at Oncoteq AG, as Global Program Leader.

Steven Mortier brings more than two decades of experience from clinical drug development and program/project leadership positions in various therapeutic areas, with focus on oncology and infectious diseases from across biotech, big pharma, and nonprofit organizations. Please join us in welcoming Steven at Oncoteq and wishing him great success in his new role.

For setting up meeting at J.P. Morgan 2024, San Francisco

Sarah Holland, Chief Business Officer

Sarah Holland

Chief Business Officer
PhD, MBA